Skip to main content
An official website of the United States government

PET Imaging with 18F-FSPG in Detecting Tumors in Patients with Advanced Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Trial Status: withdrawn

This clinical trial studies how well positron emission tomography (PET) with fluorine F 18 L-glutamate derivative BAY94-9392 (18F-FSPG) works in detecting tumors in patients with advanced epithelial ovarian, fallopian tube, or peritoneal cancer. PET imaging using 18F-FSPG may identify tumors when they are smaller and more responsive to various treatment(s).